ASX 200 gives up rally to finish Thursday’s session flat

The ASX 200 benchmark finished flat on Thursday, following two sessions where energy and healthcare stocks swapped roles.

Late rally, then late slide

ASX 200 shares continued to be dominated by oil price new as Brent crude’s rebound back above US$20 brought some risk appetite back into the market.

But it was another topsy-turvy affair with the energy and healthcare sectors swapping roles as lifters and draggers.

The benchmark ASX 200 started Wednesday’s session having lost along 5% across the previous two sessions. Early on, it looked like more of the same with the ASX 200 down 2.3%.

But then a rally started that had the index in modestly positive territory for a moment, before finishing Wednesday’s session flat at 5,221.20 points.

On Thursday, the reverse happened. Positive momentum had the ASX 200 up over 1%, before the bears took over to bring the index back to 5,217.10 points, down less than 0.1%.

On the economic data front, there was the Commonwealth Bank’s Purchasing Manager’s Index which showed a collapse in the services sector - more than expected and to a greater extent that manufacturing.

Wednesday’s heroes are Thursday’s villains

In spite of all this, all the attention was on energy. Santos, Australia’s second largest independent gas producer, surged 7.2% on Thursday after telling investors it was in a financial position to ride out the oil price crash.

The energy giant reported its first quarter results, which included a ‘strong’ operational performance with US$265 million (A$420.7 million) of free cash flow.

‘The current environment is a time for discipline,’ said Santos chief executive Kevin Gallagher, who has targeted a breakeven oil price for free cash flow of just US$25 a barrel.

Santos finished Thursday’s session at $4.28, up 6.2% thanks to Thursday’s rally. The rest of the energy sector was helped with Woodside Petroleum finishing up 0.3% to $19.97 and Oil Search flat at $2.49.

Beach Energy, which was one of the worst performers on Wednesday after its quarterly update, finished at $1.32, up 1.9% for the day.

Lynas, the world's largest rare earths miner outside China, rocketed on Thursday after telling the market the US military would give it initial funding for a heavy rare earths separation facility in Texas. Lynas ended Thursday’s session at $1.64, up 11.9% since Tuesday’s close.

A2 Milk continued to trade around all-time highs after telling the market to expect revenue of NZD$1.7-NZD$1.75 billion for full-year 2020 with earnings margins to lift to 31-32%. A2 has benefited from stockpiling amid the coronavirus. It’s shares finished Thursday at $18.60.

The ASX 200 may have been able to hold its early gains on Thursday had it not been for the healthcare shares that dragged the index into the red. On Wednesday it was the reverse.

Blood plasma heavyweight CSL lost ground late in the session. The healthcare giant lost 0.9% from Tuesday’s close to finish at $304.77.

Meanwhile, Ramsay Health Care lost 6.1% to close $60.59 after launching a $1.2 billion capital raise.

Practise trading indices like the ASX 200, currencies and equities with an IG demo account now. Click here to find out more.


The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take your position.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.